Research
Hormonal
Testosterone replacement therapy resulted in a significant increase in lean body mass from 46,906 ± 8,876 gm to 50,083 ± 7,590 gm (P < 0.001).
Practitioners may use testosterone replacement therapy to enhance lean body mass in hypogonadal patients.
StrongSupportsmedium confidence
There was significant increase in lean body mass (46,906 ± 8,876 gm vs. 50,083 ± 7,590 gm, P < 0.001).
Why this rating
Based on the prospective longitudinal intervention study design.
Source
Effect of testosterone replacement therapy on insulin sensitivity and body composition in congenital hypogonadism
KCO Reddy et al. · Journal of Postgraduate Medicine · 2021
DOI 10.4103/jpgm.jpgm_887_20
cohort · n=33Cited 10×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →